Wednesday, November 8, 2017

Lupin cracks on USFDA warning

Image result for lupin

 Lupin stock closed at Rs 860, down 17% , as company has received warning  letter from USFDA. More than 2.50 cr shares traded on Nse, as against average daily turnover of 10 lacs shares.

 The company's formulation manufacturing facilities at Goa and Indore  (Pithampur Unit II) has received warning letter from USFDA.

Intraday, the stock hit new 52 week low of Rs 845. The stock is one of the worst performer among Nifty stocks, having lost more than 43% in the last one year.

No comments:

Post a Comment